The Metabolism of Trans-cyclohexan-1,2-diol by an Acinetobacter Species
Overview
Authors
Affiliations
1. Acinetobacter TD63 was one of some thirty organisms isolated by elective culture with trans-cyclohexan-1,2-diol as sole source of carbon. The great majority of these isolates displayed the same growth spectrum as Nocardia globerula CL1 and Acinetobacter NCIB 9871 being capable of utilizing trans-cyclohexan-1,2-diol, 2-hydroxycyclohexan-1-one, cyclohexanol, cyclohexanone,1-oxa-2oxocycloheptane and adipate and were assumed to use well described metabolic pathways. 2. Acinetobacter TD63 was distinctive in being incapable of growth with cyclohexanol, cyclohexanone or 1-oxa-2-oxocycloheptane and because of this it was hoped that it would display an alternative pathway for the oxidation of trans-cyclohexan-1,2-diol. 3. Studies with cell extracts have shown the presence of inducible dehydrogenase for the conversion of trans-cyclohexan-1,2-diol to 2-hydroxycyclohexan-1-one and cyclohexan-1,2-dione and of 6-oxohexanoate to adipate. These enzymes are linked into a metabolic sequence by the action of a monooxygenase of broad specificity but efficiently capable of converting 2-hydroxy-cyclohexan-1-one into the lactone 1-oxa-2-oxo-7-hydroxycycloheptane that spontaneously rearranges to yield 6-oxohexanoate. 4. An enzyme capable of attacking cyclohexan-1,2-dione (mono-enol) in the absence of an electron donor or oxygen has also been detected. Evidence has been presented indicating that this enzyme catalyses a keto-enol tautomerization between cyclohexan-1,2-dione (mono-enol) and cyclohexan-1,2-dione (mono-hydrate) and is not involved in the pathway of ring cleavage. 5. The failure of Acinetobacter TD63 to grow with cyclohexanol, cyclohexanone or 1-oxa-2-oxocycloheptane is due not to this organism possessing a distinctive metabolic sequence but to a narrow inducer specificity coupled with an inability to form a lactone hydrolase enabling it to cleave the stable 1-oxa-2-oxocycloheptane which is an intermediate in the established pathway of cyclohexanol and cyclohexanone oxidation.
Behrle A, Douglas J, Leeder J, van Haandel L Drug Metab Dispos. 2022; 50(10).
PMID: 35878926 PMC: 9513856. DOI: 10.1124/dmd.122.000957.
Isolation and Characterization of a Cyclohexane-Metabolizing Xanthobacter sp.
Trower M, Buckland R, Higgins R, Griffin M Appl Environ Microbiol. 1985; 49(5):1282-9.
PMID: 16346796 PMC: 238543. DOI: 10.1128/aem.49.5.1282-1289.1985.
Biodegradation of cyclohexylamine by Brevibacterium oxydans IH-35A.
Iwaki H, Shimizu M, Tokuyama T, Hasegawa Y Appl Environ Microbiol. 1999; 65(5):2232-4.
PMID: 10224025 PMC: 91322. DOI: 10.1128/AEM.65.5.2232-2234.1999.
Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene.
van der Werf M, Swarts H, de Bont J Appl Environ Microbiol. 1999; 65(5):2092-102.
PMID: 10224006 PMC: 91303. DOI: 10.1128/AEM.65.5.2092-2102.1999.
New metabolites in the degradation of fluorene by Arthrobacter sp. strain F101.
Casellas M, Grifoll M, Bayona J, Solanas A Appl Environ Microbiol. 1997; 63(3):819-26.
PMID: 9055403 PMC: 168377. DOI: 10.1128/aem.63.3.819-826.1997.